INOVIQ's recent validation study of its EXO-OC test revealed it can detect stage one ovarian cancer with 96% specificity and more than 90% sensitivity, a promising advance for early detection.
The company's breast cancer screen test has also demonstrated superior accuracy over current tests.
Copyright 2024 – Finance News Network
Source: Finance News Network
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More31 Mar 2020 - BluGlass Limited (ASX:BLG) Managing Director and CEO,Giles Bourne, talks about the company's 1:1 non-renounceable rights issue, the need to fund its technology through to commercialisation, independent validation of its RPCVD technology and its response to COVID-19.
Read More25 Mar 2024 - Clean TeQ Water (ASX:CNQ) CEO Peter Voigt provides an overview of the company, discussing solutions for the global scarcity in water.
Read More19 Aug 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress with the company's IMP761 drug, which is potentially active in more than 90% of autoimmune diseases.
Read More27 May 2024 - Jonathan Belz, founder of BFA Global connects Australian and Asian family offices with top global investment opportunities in venture capital, private equity, and technology. He shares insights into the future of alternative assets and investment strategies.
Read More18 Dec 2019 - Oventus Medical Limited (ASX:OVN) Managing Director and CEO, Dr Chris Hart talks about the company's North American sales process via its lab in lab model and how this improves patient outcomes.
Read More27 May 2021 - Next Science Limited (ASX:NXS) Founder and Chief Technology Officer Dr Matthew Myntti talks about the problem of biofilms, Next Science's antimicrobial treatments and the company's recent FDA approval.
Read More11 Apr 2022 - Trigg Mining Limited (ASX:TMG) CEO and Managing Director Keren Paterson discusses the global demand for potash, the difference between sulphate of potash and muriate of potash, and the company's flagship project at Lake Throssell in Western Australia.
Read More29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More05 Dec 2019 - Memphasys Limited (ASX:MEM) Executive Chairman, Alison Coutts talks about progress with the company's human assisted reproductive device for the separation of sperm cells in IVF clinics.
Read More
